16th IHIW: International histocompatibility working group in hematopoietic cell transplantation

International Journal of Immunogenetics

Volumn 40, Issue 1, 2013, Pages 2-10

  Petersdorf, E W ^a   Malkki, M ^a   Hsu, K ^b   Bardy, P ^c   Cesbron, A ^d   Dickinson, A ^e   Dubois, V ^d   Fleischhauer, K ^f   Kawase, T ^g,h   Madrigal, A ⁱ   Morishima, Y ^g,h   Shaw, B ^j   Spellman, S ^k   Spierings, E ^l   Stern, M ^m   Tiercy, J M ⁿ   Velardi, A ^o   Gooley, T ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g Japan Marrow Donor Program   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^j ROYAL MARSDEN HOSPITAL   (United Kingdom)

^k CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁿ UNIVERSITY HOSPITAL   (Switzerland)

^o European Group for Blood and Marrow Transplantation   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; HLA DP ANTIGEN; HLA DR15 ANTIGEN; LIGAND; LIGAND KIR; MINOR HISTOCOMPATIBILITY ANTIGEN; NON INHERITED MATERNAL ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; CANCER SURVIVAL; CONFERENCE PAPER; CORD BLOOD STEM CELL TRANSPLANTATION; DEMOGRAPHY; ETHNIC DIFFERENCE; GENE MAPPING; GENETIC POLYMORPHISM; GRAFT RECIPIENT; HAPLOTYPE; HEALTH CARE ORGANIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY COMPLEX; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INTERNATIONAL HISTOCOMPATIBILITY WORKING GROUP; LEUKEMIA RELAPSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; RACE DIFFERENCE; RISK ASSESSMENT; UMBILICAL CORD BLOOD;

GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOGENETICS;

EID: 84872267341     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/iji.12022     Document Type: Conference Paper

References (15)

1. Bettens, F., Passweg, J., Schanz, U., Chalandon, Y., Heim, D., Güngör, T. et al. (2012) Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. Biology of Blood and Marrow Transplantation, 18, 608.
2. Chien, J.W., Zhang, X.C., Fan, W., Wang, H., Zhao, L.P., Martin, P.J., Storer, B.E., Boeckh, M., Warren, E.H. & Hansen, J.A. (2012) Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood, 119, 5311.
3. Fleischhauer, K., Shaw, B.E., Gooley, T., Malkki, M., Bardy, P., Bignon, J.D. et al. (2012) Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncology, 13, 366.
4. Hsu, K.C., Gooley, T., Malkki, M., Pinto-Agnello, C., Dupont, B., Bignon, J.D. et al. (2006) KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation, 12, 828.
5. Kawase, T., Morishima, Y., Malkki, M., Gooley, T.A., Hsu, K.C., Dupont, B. et al. (2011) Universal role for HLA-C and KIR2Dl ligand mismatch in severe acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation (U-HSCT) in Japanese and Caucasian transplant recipients: an analysis on behalf of International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 17, S165 (Abstract).
6. Malkki, M., Gooley, T., Dubois, V., Horowitz, M. & Petersdorf, E.W. (2007) Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation. Tissue Antigens, 69(Suppl 1), 50.
7. Morishima, Y., Kawase, T., Morishima, S., Malkki, M., Spellman, S.R., Velardi, A. & Petersdorf, E.W. (2009) Impact of donor-recipient ethnicity on risk of acute graft-versus-host disease, leukemia relapse and survival in hematopoietic stem cell transplantation from HLA-compatible unrelated donors. A report from the International Histocompatibility Workshop Group. Blood (ASH Annual Meeting Abstracts), 114, 871.
8. Petersdorf, E.W., Malkki, M., Gooley, T.A., Spellman, S.R., Haagenson, M.D., Horowitz, M.M. & Wang, T. (2012) MHC-Resident variation affects risks after unrelated donor hematopoietic cell transplantation. Science Translational Medicine, 4, 144ra101.
9. Rocha, V., Spellman, S., Zhang, M.J., Ruggeri, A., Purtill, D., Brady, C. et al. (2012) Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation, 18, 1890.
10. van Rood, J.J., Scaradavou, A. & Stevens, C.E. (2012) Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation. Proceedings of the National Academy of Sciences of the United States of America, 109, 2509.
11. Stern, M., Passweg, J., Tiercy, J.M., Genitsch, A., Meyer-Monard, S., Heim, D., Tichelli, A., Gratwohl, A. & Nissen-Druey, C. (2006) Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 1169.
12. Venstrom, J.M., Gooley, T.A., Spellman, S., Pring, J., Malkki, M., Dupont, B., Petersdorf, E. & Hsu, K.C. (2010) Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood, 115, 3162.
13. Venstrom, J.M., Pittari, G., Gooley, T.A., Chewning, J.H., Spellman, S., Haagenson, M. et al. (2012) HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. New England Journal of Medicine, 367, 805.
14. Yanover, C., Petersdorf, E.W., Malkki, M., Gooley, T., Spellman, S., Velardi, A., Bardy, P., Madrigal, A., Bignon, J.D. & Bradley, P. (2011) HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome. Immunome Research, 20, 4.
15. Zino, E., Frumento, G., Marktel, S., Sormani, M.P., Ficara, F., Di Terlizzi, S. et al. (2004) A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood, 103, 1417.